Mannosylated engineered trichosanthin-legumain protein vaccine hydrogel for breast cancer immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mannosylated engineered trichosanthin-legumain protein vaccine hydrogel for breast cancer immunotherapy

Published:2022-12 Issue: Volume:223 Page:1485-1494
ISSN:0141-8130
Container-title:International Journal of Biological Macromolecules
language:en
Short-container-title:International Journal of Biological Macromolecules

Author:

Chen Guihua,Xiong Wei,Gu Zeyun,Gao Yanrong,Hou Jiazhen,Long Li,Wang Huiyuan,Asrorov Akmal M.,Muhitdinov Bahtiyor,Xu Qin,Huang Yongzhuo

Publisher

Elsevier BV

Subject

Molecular Biology,General Medicine,Biochemistry,Structural Biology

Reference28 articles.

1. Triple-negative breast cancer: clinical features and patterns of recurrence;Dent;Clin. Cancer Res.,2007

2. Immunotherapy for early triple negative breast cancer: research agenda for the next decade;Tarantino;NPJ Breast Cancer,2022

3. Treatment landscape of triple-negative breast cancer - expanded options, evolving needs;Bianchini;Nat. Rev. Clin. Oncol.,2022

4. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer registry;Bauer;Cancer,2007

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advancements of hydrogels in immunotherapy: Breast cancer treatment;Journal of Controlled Release;2024-08

2. Harnessing the potential of hydrogels for treatment of breast cancer: An insight;Journal of Drug Delivery Science and Technology;2024-08

3. Engineering customized nanovaccines for enhanced cancer immunotherapy;Bioactive Materials;2024-06

4. Neoantigens and cancer-testis antigens as promising vaccine candidates for triple-negative breast cancer: Delivery strategies and clinical trials;Journal of Controlled Release;2024-06

5. Aggregable gold nanoparticles for cancer photothermal therapy;Journal of Materials Chemistry B;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3